Harel Insurance Investments & Financial Services’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,693
Closed -$20K 505
2024
Q2
$20K Sell
1,693
-1,063
-39% -$12.6K ﹤0.01% 441
2024
Q1
$31K Sell
2,756
-513
-16% -$5.77K ﹤0.01% 412
2023
Q4
$28K Sell
3,269
-911
-22% -$7.8K ﹤0.01% 481
2023
Q3
$32K Sell
4,180
-937
-18% -$7.17K ﹤0.01% 506
2023
Q2
$37K Sell
5,117
-2,858
-36% -$20.7K ﹤0.01% 514
2023
Q1
$49K Buy
7,975
+2,523
+46% +$15.5K ﹤0.01% 486
2022
Q4
$24K Sell
5,452
-551
-9% -$2.43K ﹤0.01% 555
2022
Q3
$24K Buy
6,003
+2,083
+53% +$8.33K ﹤0.01% 577
2022
Q2
$20K Buy
+3,920
New +$20K ﹤0.01% 631
2022
Q1
Sell
-4,459
Closed -$35K 723
2021
Q4
$35K Buy
+4,459
New +$35K ﹤0.01% 637